Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
The combination therapy results in a significantly enhanced reduction in tumor volume when compared to either Sotrastaurin (AEB071) or BYL719 alone (p=0
Chemical Name: 4-(3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2H-tetrazol-3-ium-5-yl)-3-sulfobenzenesulfonate
InChiKey: MKXKFYHWDHIYRV-UHFFFAOYSA-N
InChi: InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25
and Smad8 phosphorylation
Ifenprodil tartrate Catalog No.:M8199-2 The combination therapy results inIfenprodil is an inhibitor of the NMDA receptor, specifically of GluN1 (glycine binding NMDA receptor subunit 1) and GluN2B (glutamate binding NMDA receptor subunit 2) subunits. Additionally, ifenprodil inhibits GIRK channels, and interacts with alpha1 adrenergic, serotonin, and sigma receptors. Product information CAS Number: 23210 58 4 Molecular Weight: 475. 53 Formula: C25H33NO8 Synonym: Ifenprodil hemitartrate Chemical Name: (2R,3R) 2,3